Halozyme names David Ramsay as interim CFO effective March 23
Go back to Halozyme names David Ramsay as interim CFO effective March 23| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 79.45 +2.44 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.01 | 52 Week High | $18.39 | |||
| Open | $77.85 | 52 Week Low | $6.96 | |||
| Day High | $79.51 | P/E | N/A | |||
| Day Low | $77.54 | EPS | $-0.58 | |||
| Volume | 1,566,233 | |||||

